Metis Global Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Metis Global Partners's LLY Position: Q1 2026 in Review
Metis Global Partners reduced its Eli Lilly (LLY) stake by 3.4% in Q1 2026, selling an estimated $1.72M and leaving 48,212 shares worth $44.3M. The position accounts for 1.09% of the portfolio, ranked #15.
Metis Global Partners first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $53.6M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Metis Global Partners held 48,212 shares of Eli Lilly worth $44.3M as of Q1 2026.
- Metis Global Partners sold 1,692 Eli Lilly shares in Q1 2026, an estimated $1.72M.
- Eli Lilly made up 1.09% of Metis Global Partners's portfolio in Q1 2026, its #15 holding.
- Metis Global Partners first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
- Metis Global Partners's Eli Lilly position peaked at $53.6M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Metis Global Partners's 13F filing for Q1 2026, filed 7 May 2026.